Helen Torley; President, Chief Executive Officer, Director; Halozyme Therapeutics Inc Nicole Labrosse; Chief Financial Officer, Senior Vice President; Halozyme Therapeutics Inc Good afternoon. My name ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

The global injectable drug delivery devices market size is calculated at USD 565 billion in 2025 and is expected to reach around USD 1,217 billion by ...

The biosimilar's safety and immunogenicity profiles were found to be comparable to those of the reference product in the trial.

Semaglutide for weight loss is given as a subcutaneous injection. This means a very ... d measure out the dose each week using a single-use syringe. When you’re first prescribed semaglutide ...

Most GLP-1 agonists are administered via injection, using a needle and syringe to deliver the medication into the fatty tissue just beneath the skin (subcutaneous injection). Common injection ...

Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...

Those microbeads are dry, stable, and highly concentrated – and crucially they can be formulated into the small volumes needed for subcutaneous injections ... via pre-filled syringes or ...

KSHB002, a 125 mg/mL pre-filled syringe injection, was evaluated in a randomized ... All participants received a single subcutaneous dose. The results demonstrated that both primary endpoints ...